1,386 Shares in Chemed Corporation $CHE Bought by Vise Technologies Inc.

Vise Technologies Inc. purchased a new position in shares of Chemed Corporation (NYSE:CHE) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,386 shares of the company’s stock, valued at approximately $646,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Chemed during the 2nd quarter worth about $211,000. Abacus FCF Advisors LLC acquired a new stake in shares of Chemed during the 2nd quarter valued at about $3,837,000. West Family Investments Inc. bought a new stake in Chemed in the second quarter valued at about $304,000. NewEdge Wealth LLC bought a new stake in Chemed in the second quarter valued at about $215,000. Finally, Citizens Financial Group Inc. RI acquired a new position in Chemed in the second quarter worth about $535,000. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 0.1%

Shares of CHE opened at $541.33 on Monday. The company has a market capitalization of $7.08 billion, a P/E ratio of 27.19, a PEG ratio of 2.05 and a beta of 0.51. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The business’s 50 day simple moving average is $499.24 and its 200-day simple moving average is $446.50. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. During the same period last year, the firm posted $4.27 EPS. The business’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be issued a $0.70 dividend. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s dividend payout ratio (DPR) is 14.06%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $530.75.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 3,537 shares of company stock worth $1,782,654 in the last quarter. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.